19. ライソゾーム病 Lysosomal storage disease Clinical trials / Disease details


臨床試験数 : 854 薬物数 : 716 - (DrugBank : 105) / 標的遺伝子数 : 70 - 標的パスウェイ数 : 191

  
2 trials found
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT03153319
(ClinicalTrials.gov)
June 5, 201711/5/2017Study to Evaluate the Safety and Efficacy of Adalimumab in MPS I and IIPhase 1/2 Study of the Effect of Adalimumab on Physical Function and Musculoskeletal Disease in Mucopolysaccharidosis Types I and IIMucopolysaccharidosis I;Mucopolysaccharidosis IIDrug: Adalimumab Injection [Humira];Drug: Saline Solution for InjectionLundquist Institute for Biomedical Innovation at Harbor-UCLA Medical CenterNULLRecruiting5 YearsN/AAll14Phase 1/Phase 2United States
2NCT02437253
(ClinicalTrials.gov)
May 20155/5/2015Effects of Adalimumab in Mucopolysaccharidosis Types I, II and VIPilot Study of the Effect of Adalimumab on Physical Function and Musculoskeletal Disease in Mucopolysaccharidosis Types I, II and VIMucopolysaccharidosis Type I;Mucopolysaccharidosis Type II;Mucopolysaccharidosis Type VIDrug: Adalimumab;Other: PlaceboLos Angeles Biomedical Research InstituteNULLCompleted5 YearsN/AAll2Phase 1/Phase 2United States